How the Filibuster Has Hurt Workers and Protected Corporate Influence
How the Filibuster Has Hurt Workers and Protected Corporate Influence
January 14, 2021
Antitrust-Plus: Evaluating Additional Policies to Tackle Labor Monopsony
Antitrust-Plus: Evaluating Additional Policies to Tackle Labor Monopsony
May 14, 2020
FedAccounts Would Provide Economic Relief—and Inclusion—in the Short and Long Term
FedAccounts Would Provide Economic Relief—and Inclusion—in the Short and Long Term
April 22, 2020
The Contribution of Shareholder Primacy to the Racial Wealth Gap
The Contribution of Shareholder Primacy to the Racial Wealth Gap
February 5, 2020
AT A GLANCE: Corporate Power, Public Power, and the Future of Prescription Drug Policy in the United States
AT A GLANCE: Corporate Power, Public Power, and the Future of Prescription Drug Policy in the United States
December 5, 2019
The Racial Rules of Corporate Power: How Extractive Corporate Power Harms Black and Brown Communities and How Race-Conscious Solutions Can Create an Inclusive Economy
The Racial Rules of Corporate Power: How Extractive Corporate Power Harms Black and Brown Communities and How Race-Conscious Solutions Can Create an Inclusive Economy
November 25, 2019
New Rules for the 21st Century: Corporate Power, Public Power, and the Future of Prescription Drug Policy in the United States
New Rules for the 21st Century: Corporate Power, Public Power, and the Future of Prescription Drug Policy in the United States
October 28, 2019
Testimony before the House Financial Services Committee Subcommittee on Investor Protection, Entrepreneurship, and Capital Markets
Testimony before the House Financial Services Committee Subcommittee on Investor Protection, Entrepreneurship, and Capital Markets
October 15, 2019